Abstract:Background: Acute lung injury (ALI) and its more severe form, acute respiratory distress syndrome (ARDS) are life threatening pulmonary diseases, and we are now lack of effective therapeutic methods. Inflammatory responses are essential for initiating ALI/ARDS. Thus, ameliorating inflammatory reaction might be beneficial for treatment of the disease. There are increasing data that phosphodiesterase-4 (PDE4)-selective inhibitors, which may elevate cellular cyclic adenosine 3', 5'-monophosphate (cAMP) level, could suppress inflammation. However, whether they could be used to treat IgG immune complex (IgG-IC)-associated ALI has not been determined.Methods: ALI is induced by treating mice with airway deposition of IgG immune complexes. Cellular cAMP concentrations are elevated by treating mice or macrophages with Rolipram/Roflumilast. The degree of pulmonary injury is reflected by lung permeability, leukocyte accumulation, histological change and expressions of pro-inflammatory mediators. 6-Bnz-cAMP and H-89 are used to regulate protein kinase A (PKA) activity, and 8-pCPT-2'-O-Me-cAMP is applied to activate exchange proteins directly activated by cAMP (Epac). Gene expressions are analyzed by real-time PCR, ELISA or Western blot. CCAAT/enhancer binding protein (C/EBP) and activation protein 1 (AP-1) transcription activities are estimated by measuring the luciferase productions.Results: IgG-IC-induced ALI is attenuated by the PDE4-selective inhibitor, which is due to reduced expressions of cytokine and chemokines. Interestingly, we find that cAMP downstream effector molecule PKA but not Epac is involved in negative regulation of IgG-IC-mediated pro-inflammatory mediators' productions. Mechanistically, activation of cAMP-PKA signal axis leads to inactivation of MAPK pathway, resulting in a decrease in C/EBP- and AP-1-mediated transcriptions of pro-inflammatory mediators.Conclusions: Our data demonstrate, for the first time, that cAMP-PKA signal is involved in down-regulation of IgG-IC-associated inflammatory responses via down-regulating MAPK activation, which is critical for transcriptional activities of C/EBP and AP-1. Collectively, our experiments provide theoretical base for the potential application of PDE4-selective inhibitor to clinic for treatment of IgG-IC-related acute lung injury.

Suppression of complement regulatory protein C1 inhibitor in vascular endothelial activation by inhibiting vascular cell adhesion molecule-1 action.

Anti-Vascular Permeability Of The Cleaved Reactive Center Loop Within The Carboxyl-Terminal Domain Of C1 Inhibitor

C1 Inhibitor Prevents Gram-negative Bacterial Lipopolysaccharide-Induced Vascular Permeability.

C1 inhibitor: biologic activities that are independent of protease inhibition.

Anti-ischemia/reperfusion of C1 inhibitor in myocardial cell injury via regulation of local myocardial C3 activity.

Tanshinone II A Attenuates TNF-α-Induced Expression of VCAM-1 and ICAM-1 in Endothelial Progenitor Cells by Blocking Activation of NF-κB.

IgG Immune Complex-Induced Acute Lung Injury is Ameliorated by Camp Via Down-Regulation of C/EBP- and AP-1-mediated Transcriptions.

C1 Inhibitor Prevents Endotoxin Shock Via A Direct Interaction with Lipopolysaccharide

Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury.

Inhibitory Effects and Mechanisms of Several Natural Active Components on Inflammatory Response of Endothelial Cell Induced by Activation of the Complement Alternative Pathway

N-terminal Domain of EcC1INH in Epinephelus Coioides Can Antagonize the LPS-stimulated Inflammatory Response.

C1 Inhibitor-Mediated Myocardial Protection from Chronic Intermittent Hypoxia-Induced Injury.

Zc3h12c Inhibits Vascular Inflammation By Repressing Nf-Kappa B Activation And Pro-Inflammatory Gene Expression In Endothelial Cells

Knockdown of circulating C1 inhibitor induces neurovascular impairment, glial cell activation, neuroinflammation, and behavioral deficits

C1 Inhibitor-Mediated Protection from Sepsis

Silencing of C5a Receptor Gene with Sirna for Protection from Gram-negative Bacterial Lipopolysaccharide-Induced Vascular Permeability.

Zc3h12c inhibits vascular inflammation by repressing NF-κB activation and pro-inflammatory gene expression in endothelial cells

Interleukin-35 Inhibits Endothelial Cell Activation by Suppressing Mapk-Ap-1 Pathway

Abstract 4954: A Novel Role of CCN3 in Regulating Endothelial Inflammation

C-type Natriuretic Peptide Attenuates LPS-induced Endothelial Activation: Involvement of P38, Akt, and NF-κB Pathways.

Lipocalin 10 is essential for protection against inflammation-triggered vascular leakage by activating LRP2-Ssh1 signaling pathway